These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29091892)

  • 1. Nitric oxide bioavailability dysfunction involves in atherosclerosis.
    Chen JY; Ye ZX; Wang XF; Chang J; Yang MW; Zhong HH; Hong FF; Yang SL
    Biomed Pharmacother; 2018 Jan; 97():423-428. PubMed ID: 29091892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-Derived Nitric Oxide as an Antiatherogenic Mechanism: Implications for Therapy.
    Sukhovershin RA; Yepuri G; Ghebremariam YT
    Methodist Debakey Cardiovasc J; 2015; 11(3):166-71. PubMed ID: 26634024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
    J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pivotal role of nitric oxide for vascular health.
    Cooke JP
    Can J Cardiol; 2004 Aug; 20 Suppl B():7B-15B. PubMed ID: 15309199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
    Böger RH; Ron ES
    Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function.
    Siekmeier R; Grammer T; März W
    J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):279-97. PubMed ID: 18945874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
    Antoniades C; Shirodaria C; Leeson P; Antonopoulos A; Warrick N; Van-Assche T; Cunnington C; Tousoulis D; Pillai R; Ratnatunga C; Stefanadis C; Channon KM
    Eur Heart J; 2009 May; 30(9):1142-50. PubMed ID: 19297385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?
    Chan NN; Chan JC
    Diabetologia; 2002 Dec; 45(12):1609-16. PubMed ID: 12488950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADMA and hyperhomocysteinemia.
    Dayal S; Lentz SR
    Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
    Pernow J; Jung C
    Cardiovasc Res; 2013 Jun; 98(3):334-43. PubMed ID: 23417041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis.
    Förstermann U; Xia N; Li H
    Circ Res; 2017 Feb; 120(4):713-735. PubMed ID: 28209797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in morbid obesity.
    Mauricio MD; Aldasoro M; Ortega J; Vila JM
    Curr Pharm Des; 2013; 19(32):5718-29. PubMed ID: 23448493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial function and oxidative stress in cardiovascular diseases.
    Higashi Y; Noma K; Yoshizumi M; Kihara Y
    Circ J; 2009 Mar; 73(3):411-8. PubMed ID: 19194043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
    Sydow K; Mondon CE; Cooke JP
    Vasc Med; 2005 Jul; 10 Suppl 1():S35-43. PubMed ID: 16444867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrergic system and plasmatic methylarginines: Evidence of their role in the perinatal programming of cardiovascular diseases.
    Bassareo PP; Mussap M; Bassareo V; Flore G; Mercuro G
    Clin Chim Acta; 2015 Dec; 451(Pt A):21-7. PubMed ID: 26004093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and endothelial dysfunction: say NO to cigarette smoking!
    Grassi D; Desideri G; Ferri L; Aggio A; Tiberti S; Ferri C
    Curr Pharm Des; 2010; 16(23):2539-50. PubMed ID: 20550504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Asymmetric dimethylarginine--a novel cardiovascular risk factor].
    Siroká R; Cibulka R; Rajdl D; Racek J
    Vnitr Lek; 2006 Mar; 52(3):249-55. PubMed ID: 16722156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-arginine, tetrahydrobiopterin, nitric oxide and diabetes.
    Hoang HH; Padgham SV; Meininger CJ
    Curr Opin Clin Nutr Metab Care; 2013 Jan; 16(1):76-82. PubMed ID: 23164986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.